Radiation Dosimetry and Biodistribution of
68Ga
FAPI
PET/CT
biodistribution
dosimetry
Journal
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
18
09
2019
accepted:
02
12
2019
pubmed:
15
12
2019
medline:
30
12
2020
entrez:
15
12
2019
Statut:
ppublish
Résumé
Targeting cancer-associated fibroblasts (CAFs) has become an attractive goal for diagnostic imaging and therapy because they can constitute as much as 90% of a tumor mass. The serine protease fibroblast activation protein (FAP) is overexpressed selectively in CAFs, drawing interest in FAP as a stromal target. The quinoline-based FAP inhibitor (FAPI) PET tracer
Identifiants
pubmed: 31836685
pii: jnumed.119.236786
doi: 10.2967/jnumed.119.236786
pmc: PMC7413240
doi:
Substances chimiques
68Ga-FAPI
0
Quinolines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1171-1177Subventions
Organisme : NCI NIH HHS
ID : P30 CA016042
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA211015
Pays : United States
Informations de copyright
© 2020 by the Society of Nuclear Medicine and Molecular Imaging.
Références
Mol Cancer Ther. 2012 Feb;11(2):257-66
pubmed: 22323494
Radiology. 2009 Apr;251(1):166-74
pubmed: 19251940
J Nucl Med. 2018 Sep;59(9):1415-1422
pubmed: 29626119
J Nucl Med. 2013 Oct;54(10):1755-9
pubmed: 23929824
Mol Med Rep. 2015 May;11(5):3203-11
pubmed: 25593080
J Nucl Med. 2019 Oct;60(10):1421-1429
pubmed: 30850501
J Nucl Med. 2019 Mar;60(3):386-392
pubmed: 30072500
J Nucl Med. 2019 Jun;60(6):801-805
pubmed: 30954939
PLoS One. 2015 Mar 16;10(3):e0116683
pubmed: 25775399
Eur J Nucl Med Mol Imaging. 2016 Oct;43(11):1962-70
pubmed: 27207281
Oncogene. 2018 Aug;37(32):4343-4357
pubmed: 29720723
Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2456-2474
pubmed: 30218316
J Nucl Med. 2018 Sep;59(9):1423-1429
pubmed: 29626120
Nat Rev Drug Discov. 2019 Feb;18(2):99-115
pubmed: 30470818
Int J Mol Med. 2018 Jan;41(1):275-283
pubmed: 29115573
BMC Cancer. 2018 Nov 12;18(1):1099
pubmed: 30419872
Proc Natl Acad Sci U S A. 1990 Sep;87(18):7235-9
pubmed: 2402505
Cancers (Basel). 2015 Dec 11;7(4):2443-58
pubmed: 26690480
Nat Med. 2011 Nov 07;17(11):1359-70
pubmed: 22064426
Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2569-2580
pubmed: 31388723
Cancer Biol Ther. 2014 Oct;15(10):1413-22
pubmed: 25046247
Proteomics Clin Appl. 2014 Jun;8(5-6):454-63
pubmed: 24470260
FEBS Open Bio. 2013 Dec 08;4:43-54
pubmed: 24371721
Ann ICRP. 1991;21(1-3):1-201
pubmed: 2053748
Cancers (Basel). 2019 Mar 06;11(3):
pubmed: 30845711
Pathol Oncol Res. 2019 Jan;25(1):369-376
pubmed: 29134462
Eur J Nucl Med Mol Imaging. 2010 Jun;37(6):1238-50
pubmed: 20411259
Protoplasma. 2018 Jan;255(1):375-386
pubmed: 28620698
Eur J Nucl Med Mol Imaging. 2016 Aug;43(9):1611-20
pubmed: 27260521
J Nucl Med. 2018 Oct;59(10):1494-1499
pubmed: 30002109
J Nucl Med. 2009 Mar;50(3):477-84
pubmed: 19258258
Eur J Nucl Med Mol Imaging. 2019 Jul;46(8):1754-1755
pubmed: 31119317
JCI Insight. 2017 Oct 5;2(19):
pubmed: 28978805